Correlation Between ARK Genomic and Fidelity MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ARK Genomic and Fidelity MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARK Genomic and Fidelity MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ARK Genomic Revolution and Fidelity MSCI Health, you can compare the effects of market volatilities on ARK Genomic and Fidelity MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARK Genomic with a short position of Fidelity MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARK Genomic and Fidelity MSCI.

Diversification Opportunities for ARK Genomic and Fidelity MSCI

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between ARK and Fidelity is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding ARK Genomic Revolution and Fidelity MSCI Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity MSCI Health and ARK Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARK Genomic Revolution are associated (or correlated) with Fidelity MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity MSCI Health has no effect on the direction of ARK Genomic i.e., ARK Genomic and Fidelity MSCI go up and down completely randomly.

Pair Corralation between ARK Genomic and Fidelity MSCI

Given the investment horizon of 90 days ARK Genomic Revolution is expected to generate 3.4 times more return on investment than Fidelity MSCI. However, ARK Genomic is 3.4 times more volatile than Fidelity MSCI Health. It trades about 0.02 of its potential returns per unit of risk. Fidelity MSCI Health is currently generating about 0.04 per unit of risk. If you would invest  2,509  in ARK Genomic Revolution on September 1, 2024 and sell it today you would earn a total of  89.00  from holding ARK Genomic Revolution or generate 3.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

ARK Genomic Revolution  vs.  Fidelity MSCI Health

 Performance 
       Timeline  
ARK Genomic Revolution 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ARK Genomic Revolution are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable forward-looking signals, ARK Genomic is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Fidelity MSCI Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fidelity MSCI Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Fidelity MSCI is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

ARK Genomic and Fidelity MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ARK Genomic and Fidelity MSCI

The main advantage of trading using opposite ARK Genomic and Fidelity MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARK Genomic position performs unexpectedly, Fidelity MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity MSCI will offset losses from the drop in Fidelity MSCI's long position.
The idea behind ARK Genomic Revolution and Fidelity MSCI Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stocks Directory
Find actively traded stocks across global markets